Fidelis Capital Partners, LLC Abb Vie Inc. Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 23,159 shares of ABBV stock, worth $3.99 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,159
Previous 16,164
43.28%
Holding current value
$3.99 Million
Previous $2.5 Billion
96.4%
% of portfolio
0.01%
Previous 0.55%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,650Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$29.4 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$24.6 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13.4 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.83 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.29 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $305B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...